Ezetimibe for Arrhythmia Recurrence After AF Ablation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 120 participants.
Also called NCT07752758
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 120 participants
- Registry
-
NCT07752758
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07752758. Randomized; single masking; primary purpose treatment. Start 2026-08-15 (anticipated); primary completion 2028-06-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ezetimibe for Arrhythmia Recurrence After AF Ablation
- Acronym
- EAFA
- Condition
- Atrial Fibrillation
- Condition
- Post-Catheter Ablation Atrial Arrhythmia Recurrence
- Intervention (Drug)
- Ezetimibe
- Intervention (Other)
- Standardized post-ablation clinical management
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
Record details
- Record id
cardio:ct-nct07752758- Content hash
15cd3c1f1c5cfdb79f694f9beef7aa4f02d5416f49bd92c50dbd9a9dcc77e36c